Hepatocellular carcinoma
Conditions
Interventions
Non response group:None
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age greater than 18 years old; (2) The patient was diagnosed with hepatocellular carcinoma and was treated with PD-1 antibody combined with lenvatinib; (3) Routine ultrasound and contrast-enhanced ultrasound examination within one week before receiving treatment; (4) Conventional ultrasound, contrast-enhanced ultrasound, enhanced magnetic resonance or computed tomography after combination therapy.
Exclusion criteria
Exclusion criteria: (1) The patient receives local treatment before or during treatment; (2) Pregnant and lactating women; (3) The patient is allergic to eggs, milk, seafood, and contrast media, and cannot undergo ultrasound contrast examination; (4) Previous diagnosis of malignant tumors other than hepatocellular carcinoma; (5) Incomplete clinical data or ultrasound examination; (6) History of liver surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Residual viable tumor; | — |
Countries
China
Contacts
Public ContactLuo Yukun
Chinese PLA General Hospital
Outcome results
None listed